These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 38405343)

  • 1. ADSS: A Composite Score to Detect Disease Progression in Alzheimer's Disease.
    Shan G; Lu X; Li Z; Caldwell JZK; Bernick C; Cummings J
    J Alzheimers Dis Rep; 2024; 8(1):307-316. PubMed ID: 38405343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ADCOMS: a composite clinical outcome for prodromal Alzheimer's disease trials.
    Wang J; Logovinsky V; Hendrix SB; Stanworth SH; Perdomo C; Xu L; Dhadda S; Do I; Rabe M; Luthman J; Cummings J; Satlin A
    J Neurol Neurosurg Psychiatry; 2016 Sep; 87(9):993-9. PubMed ID: 27010616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lecanemab in Early Alzheimer's Disease.
    van Dyck CH; Swanson CJ; Aisen P; Bateman RJ; Chen C; Gee M; Kanekiyo M; Li D; Reyderman L; Cohen S; Froelich L; Katayama S; Sabbagh M; Vellas B; Watson D; Dhadda S; Irizarry M; Kramer LD; Iwatsubo T
    N Engl J Med; 2023 Jan; 388(1):9-21. PubMed ID: 36449413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessing the Clinical Meaningfulness of the Alzheimer's Disease Composite Score (ADCOMS) Tool.
    Tahami Monfared AA; Lenderking WR; Savva Y; Ladd MK; Zhang Q;
    Neurol Ther; 2022 Sep; 11(3):1085-1100. PubMed ID: 35513767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Staging Disease Severity Using the Alzheimer's Disease Composite Score (ADCOMS): A Retrospective Data Analysis.
    Tahami Monfared AA; Houghton K; Zhang Q; Mauskopf J;
    Neurol Ther; 2022 Mar; 11(1):413-434. PubMed ID: 35099758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Consistency of efficacy results across various clinical measures and statistical methods in the lecanemab phase 2 trial of early Alzheimer's disease.
    Dhadda S; Kanekiyo M; Li D; Swanson CJ; Irizarry M; Berry S; Kramer LD; Berry DA
    Alzheimers Res Ther; 2022 Dec; 14(1):182. PubMed ID: 36482412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Alzheimer's Prevention Initiative Composite Cognitive Test: a practical measure for tracking cognitive decline in preclinical Alzheimer's disease.
    Langbaum JB; Ellison NN; Caputo A; Thomas RG; Langlois C; Riviere ME; Graf A; Lopez Lopez C; Reiman EM; Tariot PN; Hendrix SB
    Alzheimers Res Ther; 2020 May; 12(1):66. PubMed ID: 32460855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methodological Aspects of the Phase II Study AFF006 Evaluating Amyloid-beta -Targeting Vaccine AFFITOPE® AD02 in Early Alzheimer's Disease - Prospective Use of Novel Composite Scales.
    Hendrix S; Ellison N; Stanworth S; Tierney L; Mattner F; Schmidt W; Dubois B; Schneeberger A
    J Prev Alzheimers Dis; 2015 Jun; 2(2):91-102. PubMed ID: 26866015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and efficacy of lecanemab for Alzheimer's disease: a systematic review and meta-analysis of randomized clinical trials.
    Qiao Y; Chi Y; Zhang Q; Ma Y
    Front Aging Neurosci; 2023; 15():1169499. PubMed ID: 37213538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel anti-amyloid-beta (Aβ) monoclonal antibody lecanemab for Alzheimer's disease: A systematic review.
    Chowdhury S; Chowdhury NS
    Int J Immunopathol Pharmacol; 2023; 37():3946320231209839. PubMed ID: 37902139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alzheimer's Disease Composite Score: A Post-Hoc Analysis Using Data from the LipiDiDiet Trial in Prodromal Alzheimer's Disease.
    Hendrix SB; Soininen H; van Hees AMJ; Ellison N; Visser PJ; Solomon A; Attali A; Blennow K; Kivipelto M; Hartmann T
    J Prev Alzheimers Dis; 2019; 6(4):232-236. PubMed ID: 31686094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ADCOMS sensitivity versus baseline diagnosis and progression phenotypes.
    Evenden D; Prosser A; Michopoulou S; Kipps C;
    Alzheimers Dement (Amst); 2024; 16(1):e12540. PubMed ID: 38406608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Path to Improved Alzheimer's Care: Simulating Long-Term Health Outcomes of Lecanemab in Early Alzheimer's Disease from the CLARITY AD Trial.
    Tahami Monfared AA; Ye W; Sardesai A; Folse H; Chavan A; Aruffo E; Zhang Q
    Neurol Ther; 2023 Jun; 12(3):863-881. PubMed ID: 37009976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alzheimer's Disease Assessment Scale-Cognitive subscale variants in mild cognitive impairment and mild Alzheimer's disease: change over time and the effect of enrichment strategies.
    Podhorna J; Krahnke T; Shear M; Harrison JE;
    Alzheimers Res Ther; 2016 Feb; 8():8. PubMed ID: 26868820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Influence of Baseline Alzheimer's Disease Severity on Cognitive Decline and CSF Biomarkers in the NILVAD Trial.
    Abdullah L; Crawford F; Tsolaki M; Börjesson-Hanson A; Olde Rikkert M; Pasquier F; Wallin A; Kennelly S; Ait-Ghezala G; Paris D; Hendrix S; Blennow K; Lawlor B; Mullan M
    Front Neurol; 2020; 11():149. PubMed ID: 32210906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Power analysis to detect treatment effects in longitudinal clinical trials for Alzheimer's disease.
    Huang Z; Muniz-Terrera G; Tom BDM
    Alzheimers Dement (N Y); 2017 Sep; 3(3):360-366. PubMed ID: 28890916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cognitive composite score association with Alzheimer's disease plaque and tangle pathology.
    Malek-Ahmadi M; Chen K; Perez SE; He A; Mufson EJ
    Alzheimers Res Ther; 2018 Sep; 10(1):90. PubMed ID: 30205840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lecanemab Clarity AD: Quality-of-Life Results from a Randomized, Double-Blind Phase 3 Trial in Early Alzheimer's Disease.
    Cohen S; van Dyck CH; Gee M; Doherty T; Kanekiyo M; Dhadda S; Li D; Hersch S; Irizarry M; Kramer LD
    J Prev Alzheimers Dis; 2023; 10(4):771-777. PubMed ID: 37874099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimal Weighting of Preclinical Alzheimer's Cognitive Composite (PACC) Scales to Improve their Performance as Outcome Measures for Alzheimer's Disease Clinical Trials.
    Wang X; Jacobs D; Salmon DP; Feldman HH; Edland SD
    Int J Stat Med Res; 2023 Feb; 12():90-96. PubMed ID: 38487620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-Term Health Outcomes of Lecanemab in Patients with Early Alzheimer's Disease Using Simulation Modeling.
    Tahami Monfared AA; Tafazzoli A; Ye W; Chavan A; Zhang Q
    Neurol Ther; 2022 Jun; 11(2):863-880. PubMed ID: 35469060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.